Healthcare Fraud & Abuse, 2nd Edition, 2010 Cumulative Supplement
ISBN-10:
1570189080
ISBN-13:
9781570189081
Author(s): ABA HEALTH LAW SECTION
Edition: 2nd Edition, 2010 Supplement
Released: Dec 21, 2010
Format: Paperback, 586 pages
Description:
Highlights in the 2010 Cumulative Supplement include analysis of the Patient Protection and Affordable Health Care Act in a number of chapters, examining it from different perspectives including its impact on Stark law, the federal anti-kickback intent standard, compliance program requirements, the Medicare Part D Program, and the Medicare Coverage Gap Discount Program; expanded discussion of the 2009 Fraud Enforcement and Recovery Act and the 2009 False Claims Act amendments; new topics on Allison Engine, reverse false claims law, statute of limitations case law, and whistleblower retaliation case law; analysis of the 2010 Supreme Court decision in Merck & Co. Inc. v. Reynolds and its impact on early disclosure of potential enforcement actions; 2009 proposed regulatory changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs; and review of the Medicare Physicians Fee Schedule 2010 Final Rule.
Best prices to buy, sell, or rent ISBN 9781570189081
Frequently Asked Questions about Healthcare Fraud & Abuse, 2nd Edition, 2010 Cumulative Supplement
You can buy the Healthcare Fraud & Abuse, 2nd Edition, 2010 Cumulative Supplement book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .
If you’re interested in selling back the Healthcare Fraud & Abuse, 2nd Edition, 2010 Cumulative Supplement book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Healthcare Fraud & Abuse, 2nd Edition, 2010 Cumulative Supplement book, the best buyback offer comes from and is $ for the book in good condition.
Not enough insights yet.
Not enough insights yet.